Corporate Board Profile
Tech Score: 10/100
1 mention(s) identify DR. ALAN COLMAN as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| VOLITIONRX LTD | 2016-08-22 | Dr. Colman has extensive experience in biochemistry, stem cell research and pathology. | Dr. Colman has a strong background in biochemistry and has worked in the field of stem cell research, which often involves technical skills related to software for data analysis and research applications. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-09-16 | Dr. Colman has extensive experience in the molecular biology field where he has worked in the production of transgenic livestock. |
| 2016-08-22 | Dr. Colman has extensive experience in biochemistry, stem cell research and pathology. |
| 2017-07-24 | Dr. Colman is currently a visiting scholar at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2018-07-20 | Dr. Colman is currently a Visiting Scholar at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2019-04-29 | Dr. Colman is currently a Visiting Scholar at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2020-04-29 | Dr. Colman is currently an Associate at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2021-04-29 | Dr. Colman is currently an Associate at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2022-04-28 | Dr. Colman is currently an Associate at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2023-04-28 | Dr. Colman is currently an Associate at the Harvard University Department of Stem Cell and Regenerative Biology. |
| 2024-05-13 | Dr. Colman received a B.A., M.A. and Ph.D. from Oxford University. |
Data sourced from SEC filings. Last updated: 2025-07-01